EBITDA Multiple Valuation
The Most Widely Used Market Approach in Professional Business Valuation
The EBITDA multiple method values a business by applying an industry-appropriate multiple to its Earnings Before Interest, Taxes, Depreciation, and Amortisation — benchmarked against comparable public companies and private M&A transactions. It is the dominant market approach in M&A advisory, private equity, and professional business appraisal.
What Is the EBITDA Multiple Method?
The EBITDA multiple method — also called the Enterprise Value / EBITDA (EV/EBITDA) multiple method — values a business by multiplying its EBITDA by an industry-appropriate multiple derived from comparable public companies and recent private M&A transactions. It is the most widely used market approach in M&A advisory, leveraged buyout analysis, and private company valuation.
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) is used as the earnings metric because it approximates operating cash flow, is capital structure-neutral, and enables direct comparison between companies regardless of their financing decisions, tax situations, or depreciation policies.
The method is fast, transparent, and directly anchored in observable market data — making it the default method for deal pricing in private equity and the primary cross-check against DCF in most professional valuation engagements.
The EBITDA Multiple Formula
WORKED EXAMPLE
Subject company EBITDA: $4.2M
Industry EV/EBITDA multiple (median of comparables): 8.5x
Enterprise Value: $4.2M × 8.5x = $35.7M
Less: Net Debt: ($3.1M)
Equity Value: $32.6M
How Equitest Implements the EBITDA Multiple
Equitest doesn't just apply a generic multiple from a table. It derives the applicable multiple range from live comparable company data and adjusts it for the subject company's specific risk and growth characteristics.
EBITDA Normalisation
Equitest normalises the subject company's EBITDA in Chapter 8, removing non-recurring items, owner compensation adjustments, and related-party transactions to arrive at a maintainable earnings figure that is comparable to peers.
Comparable Company Benchmarking
Equitest pulls EV/EBITDA multiples from 50,000+ public companies filtered by industry, geography, size, and growth profile. Chapter 7 and 13 present the comparable universe with key metrics, and Equitest identifies the appropriate multiple range — low, median, high — for the subject industry.
Multiple Selection & Application
The selected multiple is applied to the normalised EBITDA to produce Enterprise Value. Equitest calculates results at three points — low, central, and high multiples — presenting a value range rather than a single point estimate, anchored to the Football Field Chart in Chapter 40.
M&A Transaction Cross-Check
Chapter 19 (Comparable Transactions) cross-checks the public company multiples against private M&A deal multiples from Equitest's proprietary transaction database. Private deals typically trade at a premium to public multiples due to control premiums — this analysis quantifies that gap.
Private Company Discounts
Public company multiples must be adjusted for private company risk factors. Equitest applies the Discount for Lack of Marketability (DLOM) using four quantitative models in Chapter 38 — ensuring the final value conclusion appropriately reflects the illiquidity of a private business interest.
Football Field Chart
The EBITDA multiple value range feeds into the Football Field Chart alongside DCF, Revenue Multiple, EBIT Multiple, and all other active methods — presenting a visual reconciliation of every method's output in a single chart, the standard presentation format for M&A advisory work.
Representative EV/EBITDA Multiples by Industry
Reference ranges only — actual multiples vary by size, growth, profitability, and market conditions. Equitest derives live multiples from current comparable company data.
| Industry | Low | Median | High | Key Drivers |
|---|---|---|---|---|
| Software / SaaS | 12x | 18x | 35x+ | ARR growth, NRR, LTV/CAC |
| Healthcare Services | 8x | 12x | 18x | Reimbursement rates, census, payor mix |
| Industrial Manufacturing | 5x | 7x | 10x | Backlog, margins, capex intensity |
| Business Services | 6x | 9x | 14x | Customer concentration, recurring revenue |
| Food & Beverage | 5x | 8x | 12x | Brand strength, distribution, margins |
| Financial Services | 6x | 10x | 16x | AUM, fee structure, compliance profile |
| Retail | 4x | 6x | 9x | Same-store sales, e-commerce penetration |
| Construction | 4x | 6x | 9x | Backlog, contract type, cyclicality |
| Professional Services | 5x | 8x | 12x | Key-person risk, revenue concentration |
Equitest pulls live multiples from 50,000+ public comparable companies filtered by industry, geography, and size — not static table references.
What Drives the EBITDA Multiple Higher or Lower
Factors That Expand the Multiple
Factors That Compress the Multiple
When to Use the EBITDA Multiple Method
M&A Deal Pricing
EV/EBITDA is the primary deal pricing metric in private equity and M&A advisory. Buyers reference EBITDA multiples to frame offers; sellers use them to assess reasonableness. It is the language of M&A negotiation.
Capital Structure-Neutral Comparison
Because EBITDA is computed before interest, it allows comparison between companies with different debt levels — essential when benchmarking a leveraged buyout target against unlevered peers.
Profitable Businesses with Stable Earnings
The EBITDA method works best for companies with consistent, positive EBITDA — typically established businesses in the $1M–$500M revenue range with 3+ years of operating history.
DCF Cross-Check
The EBITDA multiple is the most important cross-check against a DCF result. If the DCF implies a 4x EBITDA multiple in an industry where comps trade at 8x, that discrepancy demands explanation — either the DCF assumptions are wrong or the market is mispricing.
LBO & Private Equity Analysis
LBO models are priced on entry and exit EV/EBITDA multiples. PE firms use EBITDA multiples to set acquisition prices, model leverage capacity, and project exit valuations at the end of the hold period.
Comparable Company Benchmarking
Presenting a business's valuation in EBITDA multiple terms immediately communicates where it stands relative to peers — above, at, or below the sector median — without requiring the audience to follow a DCF model.
When EBITDA Multiple Is Not the Right Method
Strengths and Limitations
Strengths
- Market-anchored — directly reflects what buyers are actually paying
- Transparent and easy to communicate to non-technical audiences
- Capital structure-neutral — comparable across different debt levels
- Fast to compute once EBITDA and comparable multiples are established
- Standard deal pricing language in M&A and private equity
Limitations
- Market-dependent — multiples compress in downturns regardless of company quality
- Ignores capex requirements — a high-capex business and a low-capex business can have the same EBITDA but very different FCF
- Requires judgment on multiple selection — the range between low and high multiples can be wide
- Excludes growth — two companies with identical EBITDA but different growth rates should not trade at the same multiple
Best practice: Never use the EBITDA multiple in isolation. Equitest presents it alongside five other multiples methods (Earnings, EBIT, Revenue, Book Value, SDE) and the DCF income approach — reconciled in the Football Field Chart — so that the final value conclusion is grounded in both market evidence and intrinsic value analysis.